ANTIBE THERAPEUTICS INC has a total of 46 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are ESPERION THERAPEUTICS INC, REVIVA PHARMACEUTICALS INC and DOMPE PHA R MA SPA RES & MFG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 5 | |
#4 | China | 4 | |
#5 | Republic of Korea | 4 | |
#6 | Brazil | 3 | |
#7 | EPO (European Patent Office) | 3 | |
#8 | South Africa | 3 | |
#9 | Israel | 2 | |
#10 | Mexico | 2 | |
#11 | New Zealand | 2 | |
#12 | Ukraine | 2 | |
#13 | Hong Kong | 1 | |
#14 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Wallace John L | 40 |
#2 | Cirino Giuseppe | 37 |
#3 | Caliendo Giuseppe | 34 |
#4 | Santagada Vincenzo | 34 |
#5 | Sparatore Anna | 17 |
#6 | Fiorucci Stefano | 11 |
#7 | Vincenzo Santagada | 4 |
#8 | Giuseppe Caliendo | 4 |
#9 | Giuseppe Cirino | 4 |
#10 | Wallace John | 3 |
Publication | Filing date | Title |
---|---|---|
US2008004245A1 | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs | |
UA102216C2 | Normal;heading 1;heading 2;heading 3;4-HYDROXYTHIOBENZAMIDE DERIVATIVES OF DRUGS | |
CN101489986A | Salts of trimebutine and N-desmethyl trimebutine | |
US2007197479A1 | Derivatives of 4- or 5-aminosalicylic acid | |
WO2005115075A2 | Salt of 4- or 5- aminosalicylic acid | |
WO2006125293A1 | Derivatives of 4- or 5-aminosalicylic acid | |
WO2006085127A1 | Topical compositions |